ANANI Pharmaceuticals, Inc. ANIP · NASDAQ
$72.67 +0.15% (+$0.11)
- Market cap
- $1.67B
- Enterprise value
- $1.64B
- P/E
- 15.7x
- Forward P/E
- 8.5x
- PEG
- -
- P/S
- 1.7x
- P/FCF
- 10.4x
- EV/EBITDA
- 6.4x
- ROIC
- 9.3%
- Bruto marža
- 65.2%
- Neto marža
- 10.8%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -0.1x
- Beta
- 0.50
- Free float
- 85.7%
O podjetju
ANI Pharmaceuticals, Inc. (ANI) is an American pharmaceutical company specializing in the development, manufacturing, and sale of generic and specialty pharmaceuticals. With a broad portfolio of pharmaceutical products, including generic versions of drug substances and specialty drugs for various therapeutic indications, ANI Pharmaceuticals is a recognized player in the pharmaceutical market. The company focuses on providing affordable and quality medicines for patients and healthcare facilities across the United States. ANI Pharmaceuticals also invests in research and development of new pharmaceutical products and seeks opportunities to expand its portfolio through acquisitions and licenses. ANI Pharmaceuticals, Inc. (ANI) shares could be suitable for investors seeking investment opportunities in the pharmaceutical industry and generic drugs.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nikhil Lalwani
Employees
970
Headquarters
Baudette
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke